Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia

Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia

Brian T Hill, Matt Kalaycio Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA Abstract: Chronic lymphocytic leukemia (CLL) is a hematologic malignancy derived from a clonal population of mature B-lymphocytes characterized by relatively lo...

Full description

Bibliographic Details
Main Authors: Hill BT, Kalaycio M
Format: Article
Language:English
Published: Dove Medical Press 2015-08-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/profile-of-obinutuzumab-for-the-treatment-of-patients-with-previously--peer-reviewed-article-OTT

Internet

http://www.dovepress.com/profile-of-obinutuzumab-for-the-treatment-of-patients-with-previously--peer-reviewed-article-OTT

Similar Items